Nantes, France – June 2, 2022, 6 p.m. – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces that the preparatory documents for the Combined General Meeting to be held on June 23, 2022 at 10 a.m. Hotel Concorde Montparnasse, 40 rue du Commandant René Mouchotte, 75014 Paris.
The notice of meeting serving as notice of meeting including the agenda and the draft resolutions as well as the procedures for participating in and voting at this Meeting was published in the BALO on May 18 and 23, 2022.
The preparatory documents for the Meeting set out in Article R. 22-10-23 of the French Commercial Code are posted on the company’s website: https://www.ose-immuno.com/assemblees-generales /